Discovery of YA8026, an optimized human constitutive androstane receptor activator from a novel ML241-derived scaffold.
A new non-CITCO chemotype for hCAR activation is established and YA8026 is identified as a promising lead compound for further development following the discovery of a structurally distinct class of hCAR activators based on the 2,4-diaminopyrimidine scaffold of ML241.